Browse by author
Lookup NU author(s): James Gardner
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2019 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.Mobile health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data and information flow, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the “Be He@lthy, Be Mobile” WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the “General Data Protection Regulation” and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of healthcare professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician- to patient-centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts and recommendations for future mHealth initiatives within EAACI are listed.
Author(s): Maria Matricardi P, Dramburg S, Alvarez-Perea A, Antolin-Amerigo D, Apfelbacher C, Atanaskovic-Markovic M, Berger U, Blaiss MS, Blank S, Boni E, Bonini M, Bousquet J, Brockow K, Buters J, Cardona V, Caubet J-C, Cavkaytar O, Elliott T, Esteban-Gorgojo I, Fonseca JA, Gardner J, Gevaert P, Ghiordanescu I, Hellings P, Hoffmann-Sommergruber K, Fusun Kalpaklioglu A, Marmouz F, Meijide Calderon A, Mosges R, Nakonechna A, Ollert M, Oteros J, Pajno G, Panaitescu C, Perez-Formigo D, Pfaar O, Pitsios C, Rudenko M, Ryan D, Sanchez-Garcia S, Shih J, Tripodi S, Van der Poel L-A, van Os-Medendorp H, Varricchi G, Wittmann J, Worm M, Agache I
Publication type: Article
Publication status: Published
Journal: Allergy: European Journal of Allergy and Clinical Immunology
Year: 2020
Volume: 75
Issue: 2
Pages: 259-272
Print publication date: 17/02/2020
Online publication date: 22/06/2019
Acceptance date: 12/06/2019
ISSN (print): 0105-4538
ISSN (electronic): 1398-9995
Publisher: Blackwell Publishing Ltd
URL: https://doi.org/10.1111/all.13953
DOI: 10.1111/all.13953
PubMed id: 31230373
Altmetrics provided by Altmetric
